Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer

NCT00593866 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

RADIATION: INTENSITY MODULATED RADIOTHERAPY
DRUG: Gemcitabine

Sponsor

University of Michigan Rogel Cancer Center

Collaborators

[object Object]